A study analyzing role of booster vaccines in increasing binding and neutralizing antibody in individuals immunized with two doses of vaccines
Latest Information Update: 15 Mar 2022
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary) ; SARS-COV-2 vaccine-inactivated-Sinovac-Biotech (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Pharmacodynamics
Most Recent Events
- 15 Mar 2022 New trial record
- 10 Mar 2022 Results published in the Journal of Infectious Diseases